Trial intelligence / Profile preview

IV vs Intrahepatic 5-FU/Leucovorin for Colorectal Liver Metastases

NCT00002692Phase 3Unknown

Sponsor
Medical Research Council
Start
Dec 1994
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of fluorouracil in colorectal cancer (CRC) (2 arms), sponsored by Medical Research Council. Primary endpoints: Overall Survival and Objective Response Rate. Status: unknown.

02

Drugs

fluorouracil
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00002692.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002692.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call